CalciMedica CBO buys 5,000 company shares
CalciMedica, Inc. director and chief business officer Eric W. Roberts reported an open-market purchase of 5,000 shares of common stock at $3.12 per share.
Rhea-AI Filing Summary
CalciMedica, Inc. director and chief business officer Eric W. Roberts reported an open-market purchase of 5,000 shares of common stock at $3.12 per share. The shares are held indirectly through an FMTC Custodian Roth IRA for his benefit. The filing also updates his direct and other indirect common stock holdings across several custodial and investment entities.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,000 shares
Net Buy
7 txns
Insider
Roberts Eric W
Role
CHIEF BUSINESS OFFICER
Bought
5,000 shs ($16K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $3.12 | $16K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 78,250 shares (Indirect, By FMTC Custodian - Roth IRA FBO Eric W. Roberts);
Common Stock — 179,706 shares (Direct);
Common Stock — 49,894 shares (Indirect, By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA);
Common Stock — 10,661 shares (Indirect, By IRA Financial Trust Company CFBO Eric W. Roberts);
Common Stock — 356,989 shares (Indirect, By Valence Investments SPV IV, LLC);
Common Stock — 66,228 shares (Indirect, By Valence Investments SPV V, LLC);
Common Stock — 316,109 shares (Indirect, By Valence Investments SPV VI, LLC)
AI-generated analysis. How Rhea-AI works. Not financial advice.
